How do primary care providers perceive their role at ensuring opioid safety? A qualitative exploration from those on the front lines

Author:

Gillette Chris,Garvick Sarah,Ip Edward Hak-Sing,Hurley Robert,Kirk Julienne,Crandall Sonia

Abstract

AbstractIntroductionPrescribing naloxone is recommended by the Centers for Disease Control and Prevention to reduce the risk of death from an opioid overdose. Naloxone is rarely prescribed, even when indicated; improving our understanding of how primary care providers (PCP) perceive their role in naloxone prescribing is essential to increase opioid medication safety. The objectives of this study were to: (1) describe how PCPs perceive their role in prescribing naloxone for patients who are at high risk of an overdose and (2) describe PCP-reported barriers and facilitators of naloxone prescribing.MethodsCurrently practicing providers completed semi-structured interviews, based on Theory of Planned Behavior, to understand their attitudes toward naloxone, their perceived role in naloxone prescribing, and facilitators/barriers to prescribing naloxone.ResultsEleven interviews were conducted with physicians (n=2), physician assistants (n=8), and a nurse practitioner (n=1). Providers held generally positive attitudes toward naloxone as a ‘rescue’ medication. Negative attitudes toward naloxone include the perception of facilitating risky opioid use. Providers suggested that whomever prescribes the opioid pain medication should be primarily responsible for prescribing naloxone. Providers noted that stigma may prevent them from discussing naloxone during clinic visits. Increasing visit time and receiving support/education from organizational and professional society leadership were identified as important facilitators of naloxone prescribing.ConclusionsWhile providers were aware of what naloxone was used for, there was reticence in discussing this medication with patients. Providers reported that whomever prescribes a pain medication should be primarily responsible for ensuring medication safety. If primary care organizations would like to improve opioid medication safety, ensuring that providers feel supported and receive needed education are essential.

Publisher

Cold Spring Harbor Laboratory

Reference34 articles.

1. Ahmad FB , Rossen LM , Sutton P. Provisional drug overdose death counts. Centers for Disease Control and Prevention website. https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm. Published July 14, 2021. Accessed July 28, 2021.

2. Overdose deaths accelerating during COVID-19. Centers for Disease Control and Prevention website. https://www.cdc.gov/media/releases/2020/p1218-overdose-deaths-covid-19.html. Published December 17, 2020. Accessed July 28, 2021.

3. The Economic Burden of Prescription Opioid Overdose, Abuse, and Dependence in the United States, 2013

4. Naloxone DrugFacts. National Institute on Drug Abuse website. https://www.drugabuse.gov/publications/drugfacts/naloxone. Published June 1, 2021. Accessed July 28, 2021.

5. CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3